There has been a slight decrease in the average time taken for OPTEGRA UK LIMITED to pay their invoices from the period of July 2018 to December 2018 to the period of January 2019 to June 2019. However, there has been an increase in the percentage of invoices paid within 30 days and a decrease in the percentage of invoices paid later than 60 days. These changes suggest an overall improvement in the company's payment efficiency.
The volatility of OPTEGRA UK LIMITED's payment patterns can be seen in the fluctuations of the percentage of invoices paid within 30 days and later than 60 days. This indicates that the company's payment process may not be consistent, and there may be room for improvement in terms of timely payments.
From July 2018 to December 2018, OPTEGRA UK LIMITED had an average time to pay of 53.5 days, with 72.2% of invoices paid within 30 days and 5.2% paid later than 60 days. The following period (January 2019 to June 2019), the average time to pay decreased to 50.6 days, with 76.5% of invoices paid within 30 days and 3.7% paid later than 60 days. This shows a slight improvement in payment efficiency, with a decrease in the percentage of invoices paid later than 60 days.
| Reporting Period | Filing Date | Average Time to Pay (days) | Paid within 30 days | Paid 31-60 days | Paid after 60 days | Not Paid within Terms |
|---|---|---|---|---|---|---|
| 01 Jul 2019 - 31 Dec 2019 | 31 Jan 2020 |
Optegra UK Limited operates Optegra's network of specialist eye hospitals and clinics across the UK, providing both private and NHS-referred ophthalmology care. Services include cataract surgery, laser eye surgery (LASIK, LASEK, ReLEx SMILE), implantable contact lenses, lens replacement and treatments for conditions such as glaucoma and age-related macular degeneration. Consultant-led care is delivered by NHS-trained ophthalmic surgeons who are Fellows of the Royal College of Ophthalmologists, with hospitals regulated by the Care Quality Commission. The wider Optegra group runs 78 hospitals and clinics across the UK and Europe and has, since 2025, become part of the EssilorLuxottica Group, a global vision care and eyewear business. This entity represents Optegra's UK hospital operations rather than the wider international group.
Generated from the company's website and Companies House records. Sources: optegra.com · optegra.com